Article

What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?

Conference|Gastrointestinal Cancers Symposium

Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.

Related Videos
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com
Related Content
Hidradenitis Suppurative, FDA, Dermatology, Bimzelx | Image Credit: © Gorodenkoff | stock.adobe.com
Published: November 20th 2024 | Updated: November 20th 2024

FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa

Ashley Gallagher, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Sjogren Disease, FDA, Nipocalimab, Lupus, Rheumatoid Arthritis | Image Credit: © fizkes | stock.adobe.com
November 19th 2024

FDA Grants Breakthrough Therapy Designation for Nipocalimab to Treat Sjögren Disease

Ashley Gallagher, Associate Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Blood cells | Image Credit: © Formoney - stock.adobe.com
November 19th 2024

Abelacimab Reduces Bleeding in AF Patients on Antiplatelet Therapy

Alexandra Gerlach, Associate Editor
AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors
November 18th 2024

AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors

Aislinn Antrim, MA, Assistant Managing Editor